Nonalcoholic fatty liver disease, metabolic syndrome, and the fight that will define clinical practice for a generation of hepatologists
Hepatology
.
2018 May;67(5):1657-1659.
doi: 10.1002/hep.29722.
Epub 2018 Apr 1.
Authors
Elliot B Tapper
1
2
3
,
Rohit Loomba
4
5
Affiliations
1
Division of Gastroenterology and Hepatology, University of Michigan.
2
Institute for Healthcare Policy and Innovation, University of Michigan.
3
Veterans Affairs Hospital, Ann Arbor, MI.
4
Division of Epidemiology, University of California at San Diego, San Diego, CA.
5
NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, San Diego, CA.
PMID:
29222913
PMCID:
PMC5906195
DOI:
10.1002/hep.29722
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Gastroenterologists
Humans
Metabolic Syndrome*
Non-alcoholic Fatty Liver Disease*
Risk Factors
Grants and funding
K23 DK090303/DK/NIDDK NIH HHS/United States
P42 ES010337/ES/NIEHS NIH HHS/United States
R01 DK106419/DK/NIDDK NIH HHS/United States